P

Inventor

PETERSEN LARS CHRISTIAN

DK14 patents
⚠️ This page may combine multiple inventors who share the name “PETERSEN LARS CHRISTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVO NORDISK AS

7 patents
US5861374AJan 19, 1999

Modified Factor VII

NOVO NORDISK AS136 citations97
US5788965AAug 4, 1998

Modified factor VII

NOVO NORDISK AS112 citations97
US6268163B1Jul 31, 2001

Identification of drug candidates modulating factor VII-mediated intracellular signaling

NOVO NORDISK AS19 citations90
US6461610B1Oct 8, 2002

Methods for modifying cell motility using factor VIIa or inactivated factor VIIa

NOVO NORDISK AS27 citations88
US5859010AJan 12, 1999

Factor VII -binding reagent

NOVO NORDISK AS17 citations82
US9228022B2Jan 5, 2016

Antibodies that are capable of specifically binding tissue factor pathway inhibitor

NOVO NORDISK AS3 citations69
US10106606B2Oct 23, 2018

Targeting tissue factor to activated platelets

NOVO NORDISK AS0 citations48

ZYMOGENETICS INC

4 patents
US5833982ANov 10, 1998

Modified factor VII

ZYMOGENETICS INC133 citations98
US5817788AOct 6, 1998

Modified factor VII

ZYMOGENETICS INC121 citations97
US6039944AMar 21, 2000

Modified Factor VII

ZYMOGENETICS INC10 citations73
US6168789B1Jan 2, 2001

Modified factor VII

ZYMOGENETICS INC1 citations51

NOVO NORDISK PHARMACEUTICALS I

1 patent
US6858587B2Feb 22, 2005

Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis

NOVO NORDISK PHARMACEUTICALS I23 citations85

NOVO NORDISK HEALTH CARE A G

1 patent
US7829529B2Nov 9, 2010

Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis

NOVO NORDISK HEALTH CARE A G0 citations45

HILDEN IDA

1 patent
US9260518B2Feb 16, 2016

Antibodies that are capable of specifically binding tissue factor pathway inhibitor

HILDEN IDA0 citations34